Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +1.13% rallied 2.04% to $179.44 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +1.06% rising 1.86% to 3,973.75 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.05% rising 1.98% to 31,880.24. This was the stock's second consecutive day of gains. Johnson & Johnson closed $7.25 below its 52-week high ($186.69), which the company achieved on April 25th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF +1.62% rose 2.54% to $334.60, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +1.37% rose 0.30% to $93.83, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE -0.23% rose 0.78% to $52.88. Trading volume (7.0 M) remained 660,734 below its 50-day average volume of 7.6 M.